Your browser doesn't support javascript.
loading
Creating a Natural Vascular Scaffold by Photochemical Treatment of the Extracellular Matrix for Vascular Applications.
Kauser, Katalin; Warner, Kevin S; Anderson, Blake; Keyes, Edgar Dalles; Hayes, R B; Kawamoto, Eric; Perkins, D H; Scott, Robert; Isaacson, Jim; Haberer, Barb; Spaans, Ann; Utecht, Ronald; Hauser, Hank; Roberts, Andrew George; Greenberg, Myles.
Afiliación
  • Kauser K; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Warner KS; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Anderson B; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Keyes ED; Department of Chemistry, University of Utah, 315 South 1400 East, Salt Lake City, UT 84112, USA.
  • Hayes RB; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Kawamoto E; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Perkins DH; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Scott R; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Isaacson J; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Haberer B; Alumend, LLC, 4800 N. Career Avenue, Suite #108, Sioux Falls, SD 57107, USA.
  • Spaans A; Alumend, LLC, 4800 N. Career Avenue, Suite #108, Sioux Falls, SD 57107, USA.
  • Utecht R; Alumend, LLC, 4800 N. Career Avenue, Suite #108, Sioux Falls, SD 57107, USA.
  • Hauser H; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
  • Roberts AG; Department of Chemistry, University of Utah, 315 South 1400 East, Salt Lake City, UT 84112, USA.
  • Greenberg M; Alucent Biomedical Inc., 675 Arapeen Dr, Suite #102, Salt Lake City, UT 84108, USA.
Int J Mol Sci ; 23(2)2022 Jan 08.
Article en En | MEDLINE | ID: mdl-35054866
The development of bioscaffolds for cardiovascular medical applications, such as peripheral artery disease (PAD), remains to be a challenge for tissue engineering. PAD is an increasingly common and serious cardiovascular illness characterized by progressive atherosclerotic stenosis, resulting in decreased blood perfusion to the lower extremities. Percutaneous transluminal angioplasty and stent placement are routinely performed on these patients with suboptimal outcomes. Natural Vascular Scaffolding (NVS) is a novel treatment in the development for PAD, which offers an alternative to stenting by building on the natural structural constituents in the extracellular matrix (ECM) of the blood vessel wall. During NVS treatment, blood vessels are exposed to a photoactivatable small molecule (10-8-10 Dimer) delivered locally to the vessel wall via an angioplasty balloon. When activated with 450 nm wavelength light, this therapy induces the formation of covalent protein-protein crosslinks of the ECM proteins by a photochemical mechanism, creating a natural scaffold. This therapy has the potential to reduce the need for stent placement by maintaining a larger diameter post-angioplasty and minimizing elastic recoil. Experiments were conducted to elucidate the mechanism of action of NVS, including the molecular mechanism of light activation and the impact of NVS on the ECM.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prótesis Vascular / Matriz Extracelular / Andamios del Tejido Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prótesis Vascular / Matriz Extracelular / Andamios del Tejido Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza